Support program for patients with unruptured intracranial aneurysms
Official title: Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial
Run by Nantes University Hospital · NCT06708078 · Data updated 2026-11-12
This study is testing a new support program to see if it helps people with unruptured intracranial aneurysms feel better and manage their condition more effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 340 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes, Loire-Atlantique) |
| Status | Recruiting |
| Started | November 7, 2023 |
| Main results expected | November 6, 2026 |
| Study ends | May 6, 2028 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06708078 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with newly diagnosed untreated intracranial aneurysms monitored by imaging.
✕Probably not a fit
Patients with a history of ruptured intracranial aneurysms or specific syndromes known to cause aneurysms may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CANHOPE program aims to evaluate the benefits of an allied health support initiative for patients with untreated unruptured intracranial aneurysms. This interventional study employs a cluster randomized controlled trial design alongside a qualitative study to gather insights from patients and caregivers. The program is inspired by the uncertainty of illness theory and seeks to enhance patient management and quality of life through tailored support. By addressing the inadequacies in the current care pathway, the study aims to provide valuable data for clinicians and decision-makers.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and management of patients with unruptured intracranial aneurysms.
How similar studies have gone: While similar approaches have been explored, this specific program is novel in its focus on allied health support for unruptured intracranial aneurysms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with newly diagnosed (\<9 months) untreated Intracranial Aneurysm * Patient with untreated Intracranial Aneurysm monitored by imaging * Patient over 18 * Patient agreeing to participate in the study and having signed the consent form Exclusion Criteria: * Patient with a history of ruptured Intracranial Aneurysm * Patient under guardianship or curatorship * Patient diagnosed with a syndrome known to cause Intracranial Aneurysm : * Marfan syndrome * AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations * Type II and IV Elhers Danlos syndrome * Autosomal dominant polycystic fibrosis * Moya-Moya syndrome * Patient with: * Dissecting or fusiform Intracranial Aneurysm * Intracranial Aneurysm associated with an arteriovenous malformation * Blister-like Intracranial Aneurysm * Mycotic Intracranial Aneurysm
Where it's running
-
CHU Nantes
Nantes, Loire-Atlantique, France Recruiting
Study contacts
- Study coordinator: Solène JOUAN
- Email: solene.jouan@chu-nantes.fr
- Phone: +33244768539
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting unruptured brain aneurysm rupture risk with blood pressure variability and 3D changes
This study follows adults with unruptured intracranial aneurysms who are managed without surgery to see if blood pressure variability and 3D changes in the aneurysm can predict rupture risk using advanced AI.
-
Early complications after flow diverter versus stent-assisted coiling for unruptured wide-neck intracranial bifurcation aneurysms
This real-world study tests which endovascular treatment—flow diverter or stent-assisted coiling—has fewer early complications in adults with unruptured wide-neck bifurcation aneurysms.
-
Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
-
Comparing protein patterns in extracellular vesicles from different blood vessels in people with ruptured or unruptured brain aneurysms
This project tries to see if protein differences in extracellular vesicles taken from different blood vessels can help diagnose or predict outcomes for people with ruptured or unruptured brain aneurysms undergoing neurointerventional procedures.
-
Clinical and economic impact of Sim&Size 3D simulation for planning implants in unruptured intracranial aneurysms
This trial will test whether using Sim&Size 3D simulation software to plan implantable devices reduces complications, procedure time, radiation exposure, and costs for adults having endovascular treatment of unruptured intracranial aneurysms.
-
Indobufen versus aspirin plus clopidogrel for preventing clots after endovascular treatment of unruptured brain aneurysms
This trial will test whether taking indobufen with clopidogrel instead of aspirin with clopidogrel better prevents clotting or bleeding after stent-assisted coiling or flow-diverter treatment in adults with unruptured intracranial aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.